期刊
DIABETES
卷 62, 期 5, 页码 1681-1688出版社
AMER DIABETES ASSOC
DOI: 10.2337/db12-0866
关键词
-
资金
- Fondation Coeur et Arteres
- LabEx (excellence laboratory)
- Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease), INSERM
- Centre National de la Recherche Scientifique
- Dementia in Neurological and Mental Diseases (DN2M)
- Fonds Europeen de Developpement Economique et Regional
- France Alzheimer
- Region Nord/Pas-de-Calais
- Ligue Europeenne Contre la Malaclie d'Alzheimer
- Agence Nationale de la Recherche [AMYTOXTAU, ADONTAGE]
- European Community [200611]
- Fonds Unique Interministeriel MEDIALZ
- Region Nord/Pas-de-Calais/Centre Hospitaller Regional Universitaire grant
The tau pathology found in Alzheimer disease (AD) is crucial in cognitive decline. Mid life development of obesity, a major risk factor of insulin resistance and type 2 diabetes, increases the risk of dementia and AD later in life. The impact of obesity on AD risk has been suggested to be related to central insulin resistance, secondary to peripheral insulin resistance. The effects of diet-induced obesity (DIO) on tau pathology remain unknown. In this study, we evaluated effects of a high-fat diet, given at an early pathological stage, in the THY-Tau22 transgenic mouse model of progressive AD-like tau pathology. We found that early and progressive obesity potentiated spatial learning deficits as well as hippocampal tau pathology at a later stage. Surprisingly, THY-Tau22 mice did not exhibit peripheral insulin resistance. Further, pathological worsening occurred while hippocampal insulin signaling was upregulated. Together, our data demonstrate that MO worsens tau phosphorylation and learning abilities in tau transgenic mice independently from peripheral/central insulin resistance. Diabetes 62:1681-1688, 2013
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据